Abstract
A collateral sensitivity or a very modest cross-resistance to BBR 3464 was found in 2 ovarian cancer cell lines with experimentally induced resistance to cisplatin Loss of mismatch repair proteins (hMLH1, hPMS2) or overexpression of nucleotide excision repair proteins (ERCC1) was not detrimental for the cellular sensitivity to BBR 3464 Moreover, interesting differences in the kinetics of formation and removal of DNA lesions at the single-gene (N-ras) level were observed between BBR 3464 and CDDP.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 1387-1390 |
Numero di pagine | 4 |
Rivista | British Journal of Cancer |
Volume | 84 |
Numero di pubblicazione | 10 |
DOI | |
Stato di pubblicazione | Pubblicato - 18 mag 2001 |
Pubblicato esternamente | Sì |